Aberdeen spin-out signs deal with major Canadian insurer for natural language generation technologies.

The life sciences fund, which spun out from Elan Corporation, has reached a $98.5m first close for its second fund, securing investment from an undisclosed strategic.

Parkwalk Advisors back Cambridge spin-out Fluid Analytics in series A round.

The two companies have set up a joint investment company which will invest a total of up to $100m in digital medicine startups.

Corporate-backed fund CapAgro participated in the early-stage round, which will support development of Olygose's nutrition technology.

Orphazyme has secured $24m in a Novo-backed round that will fund a clinical trial for its lead drug candidate, a treatment for a rare cholesterol-caused disease.

Tengelmann and Access-backed online shopping club Westwing has secured $29.7m from existing investors at a $529m valuation.